Acronym NA
Category
Marine Biotechnology
Title Utvikling av produksjonsprosess for marine lipider - Development of production process for marine lipids Programme National Programme
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source National Coordinator Per Christian Sæbø Coordinator email NA
Coordinator institution
NA
Institutions involved
NA
Start year 2013 End year 2017 Funding (€) € 394,500 Website https://prosjektbanken.forskningsradet.no/en/project/FORISS/228550?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=0&Geografi.2=%C3%98rsta Summary "The goal of the project was to develop a new process for manufacture of high value lipids from marine by-products to be used as dietary supplements and pharmaceuticals. The process shall be gentle without reducing the quality of the nutrients in the raw materials and at the same time energy and cost effective. The project uses new combinations of raw materials, technologies and markets.
Different from traditional fish oil and omega-3 concentrate manufacture, mainly giving neutrals fats (not mixable with water), this project utilizes extraction technologies that provide both neutral and polar lipids (mixable with water). Such products will also need different solutions for purification and final processing. The main goal of the project is to develop a separation technology that separates the valuable lipids at a desired composition from non-wanted components and processing aids.
The project is a cooperation with NTNU which has the needed expertise within the area of the chosen separation technology. The project is mainly based on physical testing in laboratory and pilot scale. Several separation solutions from many providers were tested in an initial screening. In the following 2 series of tests the number of solutions was reduced to 1 which was tested in pilot scale. The purpose of the pilot testing was to get a confirmation that the solution assumed to be superior really performs over time and provides the expected results at larger scale.
The results from the performed tests show that the developed separation technology sufficiently separates the desired product from the other fractions during processing. The product quality from said testing also shows that the new process is more gentle than current manufacture technology. Further upscaling and testing will have to be conducted prior to putting the developed technology into commercial scale manufacture."
Keywords
Bioprospecting;
Byproducts;
Waste valorization;
Pharmaceuticals;
Human health;
Fish;
Human food;
Bioactive compounds;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
